Biomarkers in rheumatologic disease: a review.
Publication
, Journal Article
Whitt, I; Reed, A
Published in: Minn Med
September 2009
Rheumatologic disorders are in many ways heterogeneous diseases.They have an array of clinical manifestations, involve multiple organs, produce unpredictable flares, and have widely varying clinical outcomes. Diagnosing rheumatologic diseases and predicting outcomes in a reliable way could lead to new therapeutic strategies and optimization of care. This article reviews the current literature on biological and clinical markers related to diagnosing disease, assessing for disease activity, and predicting outcomes for selected rheumatologic conditions.
Duke Scholars
Published In
Minn Med
ISSN
0026-556X
Publication Date
September 2009
Volume
92
Issue
9
Start / End Page
38 / 41
Location
United States
Related Subject Headings
- Treatment Outcome
- Rheumatic Diseases
- Prognosis
- Minnesota
- Humans
- Disease Progression
- Biomarkers
- Antirheumatic Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Whitt, I., & Reed, A. (2009). Biomarkers in rheumatologic disease: a review. Minn Med, 92(9), 38–41.
Whitt, Irene, and Ann Reed. “Biomarkers in rheumatologic disease: a review.” Minn Med 92, no. 9 (September 2009): 38–41.
Whitt I, Reed A. Biomarkers in rheumatologic disease: a review. Minn Med. 2009 Sep;92(9):38–41.
Whitt, Irene, and Ann Reed. “Biomarkers in rheumatologic disease: a review.” Minn Med, vol. 92, no. 9, Sept. 2009, pp. 38–41.
Whitt I, Reed A. Biomarkers in rheumatologic disease: a review. Minn Med. 2009 Sep;92(9):38–41.
Published In
Minn Med
ISSN
0026-556X
Publication Date
September 2009
Volume
92
Issue
9
Start / End Page
38 / 41
Location
United States
Related Subject Headings
- Treatment Outcome
- Rheumatic Diseases
- Prognosis
- Minnesota
- Humans
- Disease Progression
- Biomarkers
- Antirheumatic Agents